Christian Teschendorf
Overview
Explore the profile of Christian Teschendorf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cameron D, Grosser J, Ladigan S, Kuzin V, Iliopoulou E, Wiegard A, et al.
Sci Adv
. 2023 Oct;
9(41):eadg5109.
PMID: 37831776
Pancreatic carcinoma lacks effective therapeutic strategies resulting in poor prognosis. Transcriptional dysregulation due to alterations in KRAS and MYC affects initiation, development, and survival of this tumor type. Using patient-derived...
2.
Reissig T, Ladigan-Badura S, Steinberg A, Maghnouj A, Li T, Verdoodt B, et al.
Mol Oncol
. 2023 Aug;
17(11):2396-2414.
PMID: 37604687
Although approximately half of all metastatic colorectal cancers (mCRCs) harbour mutations in KRAS or NRAS, hardly any progress has been made regarding targeted treatment for this group over the last...
3.
Gerwert K, Schorner S, Grosserueschkamp F, Kraeft A, Schuhmacher D, Sternemann C, et al.
Eur J Cancer
. 2023 Feb;
182:122-131.
PMID: 36773401
Purpose: Microsatellite instability (MSI) due to mismatch repair (MMR) defects accounts for 15-20% of colon cancers (CC). MSI testing is currently standard of care in CC with immunohistochemistry of the...
4.
Hofheinz R, Merx K, Haag G, Springfeld C, Ettrich T, Borchert K, et al.
J Clin Oncol
. 2022 Jun;
40(32):3750-3761.
PMID: 35709415
Purpose: High pathologic complete response (pCR) rates and comparably good survival data were seen in a phase II trial combining perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy with trastuzumab...
5.
Nopel-Dunnebacke S, Jutte H, Denz R, Feder I, Kraeft A, Lugnier C, et al.
Cancer Med
. 2022 Feb;
11(8):1735-1744.
PMID: 35146948
Background: Colon cancer (CC) is a disease of elderly patients (pts.) with a median age of 73 years (yrs.). Lack of data about the effects of adjuvant chemotherapy (ACT) is...
6.
Vangala D, Ladigan S, Liffers S, Noseir S, Maghnouj A, Gotze T, et al.
Genome Med
. 2021 Jul;
13(1):116.
PMID: 34271981
Background: The development of secondary resistance (SR) in metastatic colorectal cancer (mCRC) treated with anti-epidermal growth factor receptor (anti-EGFR) antibodies is not fully understood at the molecular level. Here we...
7.
Noepel-Duennebacke S, Juette H, Feder I, Kluxen L, Basara N, Hiller W, et al.
Z Gastroenterol
. 2020 Jun;
58(6):533-541.
PMID: 32544965
Colorectal cancer is one of the leading malignancies and still accounts for almost 25 000 deaths in Germany each year. Although there is accumulating data on the molecular basis, treatment...
8.
Al-Batran S, Homann N, Pauligk C, Goetze T, Meiler J, Kasper S, et al.
Lancet
. 2019 Apr;
393(10184):1948-1957.
PMID: 30982686
Background: Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal junction adenocarcinoma. This study reports on the safety and efficacy of the docetaxel-based triplet FLOT (fluorouracil plus leucovorin, oxaliplatin and...
9.
Weisner J, Landel I, Reintjes C, Uhlenbrock N, Trajkovic-Arsic M, Dienstbier N, et al.
Cancer Res
. 2019 Mar;
79(9):2367-2378.
PMID: 30858154
Aberrations within the PI3K/AKT signaling axis are frequently observed in numerous cancer types, highlighting the relevance of these pathways in cancer physiology and pathology. However, therapeutic interventions employing AKT inhibitors...
10.
Schmiegel W, Scott R, Dooley S, Lewis W, Meldrum C, Pockney P, et al.
Mol Oncol
. 2017 Jan;
11(2):208-219.
PMID: 28106345
An accurate blood-based RAS mutation assay to determine eligibility of metastatic colorectal cancer (mCRC) patients for anti-EGFR therapy would benefit clinical practice by better informing decisions to administer treatment independent...